BD 2000E - SmartSite Needle Free Valve 0.1 mL, 100/CS
The BD 2000E SmartSite Needle Free Valve 0.1 mL is a compact, needleless IV access device designed to support safer, more efficient infusion therapy. Manufactured byBecton, Dickinson and Company, this valve enables medication administration and fluid access without the use of needles, helping reduce needlestick injuries and contamination risks in clinical environments.
Engineered with a low internal fluid displacement of 0.1 mL, the SmartSite valve supports accurate dosing and minimizes blood reflux within IV lines. Its streamlined design integrates easily into standard IV systems, supporting consistent access while maintaining a closed, needle-free pathway.
| Manufacturer | Application | Type |
| 2000E | Needleless Connector | Negative Displacement |
Key Benefits
This needle-free valve enhances clinician safety by eliminating the need for needles during IV access, directly supporting needlestick injury prevention initiatives. The low 0.1 mL displacement helps reduce medication loss and supports more precise therapy delivery.
The SmartSite design allows smooth, intuitive access with compatible luer devices, helping maintain workflow efficiency in fast-paced care settings. Its single-use construction supports infection control protocols and simplifies device management.
Compatibility and Applications
The BD 2000E SmartSite valve is compatible with standard luer-lock syringes and IV administration sets commonly used in healthcare facilities. It integrates seamlessly into peripheral IV lines, central lines, and extension sets without requiring specialized adapters.
Common applications include medication administration, IV fluid delivery, blood sampling through IV lines where permitted by protocol, and routine infusion therapy in hospitals, outpatient clinics, infusion centers, and emergency care settings.
Usage Guidelines
The valve should be connected to the IV line using standard aseptic technique. Prior to access, the valve surface should be properly disinfected according to institutional protocol. Compatible luer devices can then be attached to administer medications or fluids.
After use, the valve should be replaced according to facility policy or manufacturer guidance. The device is intended for single-patient use and should not be reused beyond recommended clinical timeframes.
Certifications, Safety Standards, and Regulatory Approvals
The BD 2000E SmartSite Needle Free Valve is manufactured under quality management systems aligned with FDA medical device regulations and internationally recognized manufacturing standards. These controls help ensure consistent performance, material integrity, and reliable valve function.
Compliance with these standards supports the valves use in regulated healthcare environments and reinforces confidence in its safety and reliability.
Comparison with Competitor Products
Compared with traditional needle-based access ports and basic needleless connectors, the BD SmartSite valve offers enhanced safety through true needle-free access and low internal volume. Some competitor connectors may have higher displacement volumes, increasing the risk of blood reflux or medication waste.
Healthcare facilities often prefer BD SmartSite valves for their consistent performance, ease of access, and strong alignment with occupational safety goals and infection prevention practices.
Typical User Profile and Application Scenarios
Typical users include nurses, physicians, infusion specialists, and other trained healthcare professionals responsible for IV therapy and medication administration.
The valve is particularly effective in acute care hospitals, infusion centers, outpatient clinics, and emergency departments where frequent IV access is required and staff safety is a priority.
Best Practices for Use and Maintenance
Best practice includes thorough disinfection of the valve surface before each access and verification of secure luer connections during use. Staff should follow institutional guidelines regarding dwell time and replacement frequency.
Proper handling and timely replacement help maintain valve integrity and reduce the risk of infection or occlusion. As a needle-free device, no sharps disposal is required for the valve itself.
Regulatory and Safety Information
The BD 2000E SmartSite Needle Free Valve is classified as a regulated medical device and complies with applicable FDA requirements. Its use supports compliance with OSHA needlestick prevention guidelines and institutional IV safety protocols.
Adhering to manufacturer instructions and facility policies ensures safe, compliant use across all clinical applications.
How to Order
The BD 2000E SmartSite Needle Free Valve 0.1 mL is available for purchase through the CIA Medical website. Add the product to your cart and complete the secure checkout process.
For bulk orders, institutional pricing, or product assistance, contact CIA Medical customer service at 312 275 5850 or use the contact form available on this page for prompt support.
